Vista Pharmaceuticals Hits New 52-Week Low at Rs. 8.25

Vista Pharmaceuticals has reached a new 52-week low, hitting Rs. 8.25 today, November 12, 2025. This marks a significant decline for the microcap company, which has seen its stock price fall consistently over the past four days, resulting in a total decrease of 5.73% during this period. The stock has underperformed its sector by 1.17%, reflecting broader challenges within the company. In terms of moving averages, Vista Pharmaceuticals is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained downward trend. Over the past year, the stock has experienced a decline of 25.63%, contrasting sharply with the Sensex, which has gained 7.30% during the same timeframe. The company's financial health appears to be under pressure, with operating losses and a weak long-term fundamental strength. Net sales have decreased at an annual rate of 8.91%, and operating profit has also declined by 8.54% over the last five years. Additionally, the company's ability to service its debt is concerning, as indicated by a negative EBIT to interest ratio of -3.92.